FRM
ISEE

Fox Run Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Fox Run Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,386
Closed -$384K – 959
2022
Q3 		$384K Sell
21,386
-2,035
-9% -$26.7K 0.15% 266
2022
Q2 		$225K Buy
+23,421
New +$294K 0.11% 391
2017
Q1 		– Sell
-19,600
Closed -$95K – 792
2016
Q4 		$95K Buy
+19,600
New +$582K 0.05% 467

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fox Run Management's ISEE Position: Q4 2022 in Review

Fox Run Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 21,386 shares — an estimated $384K sold.

Fox Run Management first reported a position in ISEE in Q4 2016 and held it in 3 quarters. The position peaked at $384K in Q3 2022. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Fox Run Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Fox Run Management sold 21,386 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $384K.
  • Fox Run Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 3 quarters.
  • Fox Run Management's IVERIC bio, Inc. Common Stock position peaked at $384K in Q3 2022.
  • 225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Fox Run Management's 13F filing for Q4 2022, filed 7 Feb 2023.